- Guide to PHARMACOLOGY
Synonyms: AMG203  | MT203
Compound class: Antibody
Comment: Namilumab (AMG203, MT203) is an IgG1κ anti-macrophage colony-stimulating factor (GM-CSF; CSF2) monoclonal antibody . It is being developed by Micromet and Nycomed for the treatment of autoimmune and chronic inflammatory diseases.
Peptide sequences and structural information for this antibody are available from its IMGT/mAb-DB entry.
|International Nonproprietary Names|
|AMG203  | MT203|
|GtoPdb PubChem SID||384403650|
|Search PubMed clinical trials||namilumab|
|Search PubMed titles||namilumab|
|Search PubMed titles/abstracts||namilumab|